A Phase I/II Trial of Intrabone Marrow Cord Blood Transplantation and Comparison of the Hematological Recovery with the Japanese Nationwide Database

Overview

Journal Bone Marrow Transplant

Specialty General Surgery

Date 2017 Jan 10

PMID 28067880

Citations 8

Authors

N Kurita

M Gosho

Y Yokoyama

T Kato

N Obara

M Sakata-Yanagimoto

Y Hasegawa

N Uchida

S Takahashi

Y Kouzai

Y Atsuta

M Kurata

T Ichinohe

S Chiba

Affiliations

Soon will be listed here.

Abstract

Intrabone marrow cord blood transplantation (IB-CBT) was proposed as a promising treatment modality to improve hematological recovery. However, clinical advantages of IB-CBT over conventional IV CBT have been unclear. We conducted a prospective single-center trial of IB-CBT to evaluate its safety and superiority in terms of hematological recovery. Fifteen adults with hematological malignancies were enrolled. A thawed and unwashed single cord blood unit was injected into the bilateral superior-posterior iliac crests under local anesthesia. Engraftments of neutrophils and platelets were achieved in 13 cases, with medians of 17 and 45 days, respectively. For the control, we extracted data from the Japanese nationwide database and compared the hematological recovery of contemporaneously transplanted 1135 CBT cases. Multivariate analysis revealed that IB-CBT enhanced platelet recovery (hazard ratio, 2.13; P=0.007), but neutrophil recovery did not differ significantly (hazard ratio, 1.70; P=0.19). Better donor chimerism was seen in the bone marrow of the ilium than of the sternum on day 14, suggesting that the local hematopoiesis at the injected site was established earlier than that at the remote bone marrow site. Collectively, IB-CBT was well tolerated and may enhance local engraftment, which promotes prompter platelet recovery than does IV-CBT.

Citing Articles

Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.

Kurita N, Nishikii H, Maruyama Y, Suehara Y, Hattori K, Sakamoto T Ann Hematol. 2023; 102(10):2895-2902.

PMID: 37589942 DOI: 10.1007/s00277-023-05410-3.

Umbilical cord blood derived cellular therapy: advances in clinical development.

Wang J, Metheny L Front Oncol. 2023; 13:1167266.

PMID: 37274288 PMC: 10232824. DOI: 10.3389/fonc.2023.1167266.

Phase I study of intra-osseous co-transplantation of a single-unit cord blood and mesenchymal stromal cells with reduced intensity conditioning regimens.

Wang J, Sanati F, Firoozmand A, Fu P, Kolk M, Reese-Koc J Front Oncol. 2023; 13:1186532.

PMID: 37207167 PMC: 10191226. DOI: 10.3389/fonc.2023.1186532.

A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin.

Nishida T, Kobayashi T, Sawa M, Masuda S, Shibasaki Y, Goto T Ann Hematol. 2021; 100(3):743-752.

PMID: 33427909 DOI: 10.1007/s00277-020-04365-z.

Bacigalupo A, Sica S, Laurenti L, Sora F, Giammarco S, Metafuni E Haematologica. 2018; 104(2):e77-e78.

PMID: 30573505 PMC: 6355502. DOI: 10.3324/haematol.2018.202598.

References

Pantin J, Hoyt Jr R, Aras O, Sato N, Chen M, Hunt T . Optimization of intrabone delivery of hematopoietic progenitor cells in a swine model using cell radiolabeling with [89]zirconium. Am J Transplant. 2015; 15(3):606-17. PMC: 8391069. DOI: 10.1111/ajt.13007. View

Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A . Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004; 351(22):2276-85. DOI: 10.1056/NEJMoa041469. View

Cashman J, Eaves C . High marrow seeding efficiency of human lymphomyeloid repopulating cells in irradiated NOD/SCID mice. Blood. 2000; 96(12):3979-81. View

Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang M, Arcese W . Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010; 11(7):653-60. PMC: 3163510. DOI: 10.1016/S1470-2045(10)70127-3. View

van Hennik P, de Koning A, Ploemacher R . Seeding efficiency of primitive human hematopoietic cells in nonobese diabetic/severe combined immune deficiency mice: implications for stem cell frequency assessment. Blood. 1999; 94(9):3055-61. View

Fischer U, Harting M, Jimenez F, Monzon-Posadas W, Xue H, Savitz S . Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2008; 18(5):683-92. PMC: 3190292. DOI: 10.1089/scd.2008.0253. View

Sanz J, Boluda J, Martin C, Gonzalez M, Ferra C, Serrano D . Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen. Bone Marrow Transplant. 2012; 47(10):1287-93. DOI: 10.1038/bmt.2012.13. View

Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y . SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood. 2002; 101(8):2924-31. DOI: 10.1182/blood-2002-09-2782. View

Oran B, Wagner J, DeFor T, Weisdorf D, Brunstein C . Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. Biol Blood Marrow Transplant. 2011; 17(9):1327-34. PMC: 4130206. DOI: 10.1016/j.bbmt.2011.01.007. View

10.

Ruggeri A, Labopin M, Sormani M, Sanz G, Sanz J, Volt F . Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen. Haematologica. 2014; 99(9):1509-15. PMC: 4562541. DOI: 10.3324/haematol.2014.109280. View

11.

Barker J, Scaradavou A, Stevens C . Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2009; 115(9):1843-9. PMC: 5003507. DOI: 10.1182/blood-2009-07-231068. View

12.

Castello S, Podesta M, Menditto V, Ibatici A, Pitto A, Figari O . Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp Hematol. 2004; 32(8):782-7. DOI: 10.1016/j.exphem.2004.05.026. View

13.

Olsson R, Remberger M, Schaffer M, Berggren D, Svahn B, Mattsson J . Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant. 2012; 48(4):537-43. DOI: 10.1038/bmt.2012.239. View

14.

Matsuoka Y, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, Sasaki Y . Human cord blood-derived primitive CD34-negative hematopoietic stem cells (HSCs) are myeloid-biased long-term repopulating HSCs. Blood Cancer J. 2015; 5:e290. PMC: 4382663. DOI: 10.1038/bcj.2015.22. View

15.

Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A . Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007; 86(3):269-74. DOI: 10.1532/IJH97.06239. View

16.

Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J . Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia. Biol Blood Marrow Transplant. 2015; 22(2):330-338. DOI: 10.1016/j.bbmt.2015.10.006. View

17.

Moscardo F, Sanz J, Senent L, Cantero S, Rubia J, Montesinos P . Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies. Haematologica. 2009; 94(6):827-32. PMC: 2688574. DOI: 10.3324/haematol.2008.000935. View

18.

Kurtzberg J, Prasad V, Carter S, Wagner J, Baxter-Lowe L, Wall D . Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008; 112(10):4318-27. PMC: 2581998. DOI: 10.1182/blood-2007-06-098020. View

19.

Kharfan-Dabaja M, Mhaskar R, Reljic T, Pidala J, Perkins J, Djulbegovic B . Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation. Cochrane Database Syst Rev. 2014; (7):CD010280. PMC: 10945354. DOI: 10.1002/14651858.CD010280.pub2. View

20.

Feng Q, Chow P, Frassoni F, Phua C, Tan P, Prasath A . Nonhuman primate allogeneic hematopoietic stem cell transplantation by intraosseus vs intravenous injection: Engraftment, donor cell distribution, and mechanistic basis. Exp Hematol. 2008; 36(11):1556-66. DOI: 10.1016/j.exphem.2008.06.010. View